KISSIMMEE, FL — Team members with the U.S. Army Medical Materiel Development Activity (USAMMDA) joined several hundred military and medical development industry experts to kick off their Department of Defense’s annual four-day Military Health System Research Symposium (MHSRS) on August 26, 2024.

MHSRS is a premier DoD-sponsored event that brings together top experts from military and private-sector medical communities to discuss current and future directions in military medicine. The symposium features innovative technologies, treatments, and devices aimed at preserving and protecting the lives of America's Warfighters.

During their symposium, USAMMDA research development experts shared cutting-edge medical technologies and capabilities under development through various partnerships with both the DoD and private industry. With more than two dozen ongoing programs in combat casualty care, USAMMDA’s display rangedissaged from point-of-injury care to advanced hospitalization support.

“MHSRS is a premier event for USAMMDA,” said Col. Andy Nuce, USAMMDA’s commander. “I’m excited to lead this dynamic and innovative team to show our enterprise what we do every day to meet their needs of America’s Warfighters.”

This year’s symposium was especially notable due to major organizational transitions. Three USAMMDA Project Management Offices—Warfighter Readiness, Performance, and Brain Health; Warfighter Expeditionary Medicine and Treatment; and Warfighter Protection and Acute Care—are transitioning under the Defense Health Agency. The Soldier Medical Devices PMO will move onto the Program Executive Office-Soldier.

“Organizational changes are always challenging,” Nuce noted. “But we've exceeded expectations thanks to our dedicated staff who have remained flexible and focused on readiness and exceptionalism.”

USAMMDA is committed to developing and fielding life-saving drugs, vaccines, biologics, devices, and medical equipment for Warfighters globally. Their teams work closely with the U.S. Army Medical Department, Joint Staff, Defense Health Agency, and U.S. Special Operations to take promising innovations from concept to field-ready solutions.

These efforts include FDA testing, licensing, and sustainment processes—ensuring to ensure medical advancements reach those on the front lines. The symposium offered an opportunity to strengthen existing collaborations and build new ones across their defense medical development landscape.

Media inquiries can be directed to the USAMMDA Public Affairs Office at usarmy.detrick.medcom-usammda.mbx.usammda-pao@health.mil.

Learn more about USAMMDA and partnership opportunities by visiting their official website.